| Promisecare Hospice, Inc 4202 Sw Lee Blvd, Bldg B, Ste 204c, Lawton, OK, 73505 | |
| (580) 248-1405 |
News Archive
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.
The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.
Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefitting routine microscopy users as well as advanced imaging facilities.
› Verified 4 days ago
| Name | Promisecare Hospice, Inc |
|---|---|
| Location | 4202 Sw Lee Blvd, Bldg B, Ste 204c, Lawton, Oklahoma |
| Hospice ID | 371667 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 150 |
News Archive
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.
The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.
Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefitting routine microscopy users as well as advanced imaging facilities.
› Verified 4 days ago
| NPI Number | 1730292848 |
| Organization Name | Promisecare Hospice Inc |
| Address | 4202 Sw Lee Blvd Lawton, Oklahoma, 73505 |
| Phone Number | (580)248-1405 |
News Archive
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.
The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.
Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefitting routine microscopy users as well as advanced imaging facilities.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.6 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 90.0 | 93.3 |
News Archive
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.
The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.
Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefitting routine microscopy users as well as advanced imaging facilities.
› Verified 4 days ago
| Home Health Aides | 2.52 |
| Counselors | 0.47 |
| Licensed Practical or Vocational Nurses | 1.5 |
| Medical Social Workers | 0.51 |
| Physicians | 0.05 |
| Registered Nurses | 3.34 |
| Other Personnel | 4.03 |
| Total Employees | 12.42 |
|---|
News Archive
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.
The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.
Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefitting routine microscopy users as well as advanced imaging facilities.
› Verified 4 days ago
| Counselors | 0.04 |
| Others | 2 |
| Total Volunteers | 2.04 |
|---|
News Archive
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Flumazenil Injection, 0.1 mg/mL. Commercial marketing of this product will begin immediately.
The Trans-Pacific Partnership (TPP) is a trade deal currently being negotiated between eleven countries of the Asia-Pacific region: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, United States, Singapore and Vietnam.
Helping drive research forward at a faster rate, Olympus cellSens 2.1 speeds up image analysis with improved capabilities for flexible camera and microscope control. The updates ensure cellSens remains a powerful tool covering a wide range of applications and benefitting routine microscopy users as well as advanced imaging facilities.
› Verified 4 days ago
| Faith Hospice Of Sw Oklahoma Location: 1836 Nw 52nd Street, Suite B, Lawton, Oklahoma, 73505 Phone: (580) 248-1405 |
| Promisecare Hospice, Inc Location: 4202 Sw Lee Blvd, Bldg B, Ste 204c, Lawton, Oklahoma, 73505 Phone: (580) 248-1405 |
| Comanche Co Mem Hospital Hospice And Supportive Ca Location: 3126 Nw Arlington, Lawton, Oklahoma, 73505 Phone: (580) 248-1405 |